T Cell Dysfunction in the Acidic Tumor Microenvironment
Acta Physiologica · 2026-06 · 242 (6)
DOI: 10.1111/apha.70260 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Physiologica, online erschienen am 22.05.2026. Verfasst von F B Christiansen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Acidosis, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danmarks Frie Forskningsfond, Kræftens Bekæmpelse, Novo Nordisk Fonden.
Abstract (Originalsprache)
Solid tumors are characterized by profound metabolic and vascular abnormalities that generate a hostile tumor microenvironment (TME) marked by extracellular acidosis, hypoxia, and nutrient deprivation. While the consequences of these conditions for cancer cell behavior have been extensively studied, their impact on anti‐tumor immune responses—particularly T cell function—has only recently gained attention. In this review, we summarize and critically discuss current knowledge on how acidic TME conditions affect the cytotoxic CD8+ T cells which are essential for anti‐tumor immunity, and the protumorigenic, regulatory T cells (Tregs). An emerging body of literature shows that TME acidosis restricts cytotoxic CD8+ T cell motility and tumor penetration, suppresses cytokine production and secretion despite preserved transcription, impairs proliferation, and reduces cytotoxic killing capacity. These effects are closely linked to acid‐induced metabolic reprogramming, including inhibition of glycolysis, altered mTOR and MYC signaling, and a shift toward fatty acid‐dependent oxidative metabolism. In contrast, Tregs, which are metabolically adapted to rely on oxidative phosphorylation and lactate utilization, are comparatively resilient to acidic stress, and acidosis can enhance their suppressive capacity, thereby further skewing the immune balance toward tolerance. We highlight emerging evidence that tumor acidosis modulates immune checkpoint pathways, including pH‐sensitive signaling through VISTA and regulation of PD‐L1 expression, with important implications for immunotherapy sensitivity. We posit that limiting tumor acidosis may enable restoration of anti‐tumor T cell function and improve therapeutic response to immune checkpoint blockade and adoptive T cell therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Förderung
- Danmarks Frie Forskningsfond
- Kræftens Bekæmpelse
- Novo Nordisk Fonden
- Carlsbergfondet
Zitieren
APA
Christiansen, F. B., Novella, E. S., Lindemann, A. V., Cordes, J. F. H., & Pedersen, S. F. (2026). T Cell Dysfunction in the Acidic Tumor Microenvironment. Acta Physiologica, 242(6). https://doi.org/10.1111/apha.70260
Vancouver
Christiansen FB, Novella ES, Lindemann AV, Cordes JFH, Pedersen SF. T Cell Dysfunction in the Acidic Tumor Microenvironment. Acta Physiologica. 2026;242(6). doi:10.1111/apha.70260
BibTeX
@article{Christiansen2026,
author = {Christiansen, F B and Novella, E S and Lindemann, A V and Cordes, J F H and Pedersen, S F},
title = {T Cell Dysfunction in the Acidic Tumor Microenvironment},
journal = {Acta Physiologica},
year = {2026},
volume = {242},
number = {6},
doi = {10.1111/apha.70260}
}
EUVIMED